NASDAQ:LNDC - Nasdaq - US5147661046 - Common Stock - Currency: USD
8.76
-0.32 (-3.52%)
The current stock price of LNDC is 8.76 USD. In the past month the price increased by 5.8%. In the past year, price decreased by -7.69%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
MDLZ | MONDELEZ INTERNATIONAL INC-A | 20.42 | 85.65B | ||
HSY | HERSHEY CO/THE | 19.28 | 32.77B | ||
KHC | KRAFT HEINZ CO/THE | 8.94 | 31.64B | ||
GIS | GENERAL MILLS INC | 12.23 | 29.99B | ||
K | KELLANOVA | 21.94 | 28.47B | ||
MKC | MCCORMICK & CO-NON VTG SHRS | 25.42 | 19.91B | ||
MKC.V | MCCORMICK & CO INC VTG COM | 25.35 | 19.85B | ||
TSN | TYSON FOODS INC-CL A | 14.37 | 19.70B | ||
HRL | HORMEL FOODS CORP | 20.58 | 16.86B | ||
SJM | JM SMUCKER CO/THE | 10.59 | 11.80B | ||
PPC | PILGRIM'S PRIDE CORP | 7.88 | 11.14B | ||
CAG | CONAGRA BRANDS INC | 9.53 | 10.69B |
Landec Corp. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Santa Maria, California and currently employs 689 full-time employees. The company designs, develops, manufactures, and sells differentiated products for biomaterials and food markets, and license technology applications to partners. Its business segments include Lifecore and Curation Foods. Its Landec’s Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, fill and finish of sterile, injectable pharmaceutical products in syringes and vials. Its services include technology development, material component changes, analytical method development, formulation development. Its Curation Foods is focused on distributing plant-based foods with clean ingredients to retail, club and foodservice channels throughout North America. Curation Foods brands include O Olive Oil & Vinegar, Yucatan, and Cabo Fresh.
LANDEC CORP
2811 Airpark Drive
Santa Maria CALIFORNIA 93455 US
CEO: Albert D. Bolles
Employees: 689
Phone: 16503061650.0
The current stock price of LNDC is 8.76 USD. The price decreased by -3.52% in the last trading session.
The exchange symbol of LANDEC CORP is LNDC and it is listed on the Nasdaq exchange.
LNDC stock is listed on the Nasdaq exchange.
10 analysts have analysed LNDC and the average price target is 14.03 USD. This implies a price increase of 60.1% is expected in the next year compared to the current price of 8.76. Check the LANDEC CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
LANDEC CORP (LNDC) has a market capitalization of 259.26M USD. This makes LNDC a Micro Cap stock.
LANDEC CORP (LNDC) currently has 689 employees.
LANDEC CORP (LNDC) has a support level at 8.73 and a resistance level at 8.86. Check the full technical report for a detailed analysis of LNDC support and resistance levels.
The Revenue of LANDEC CORP (LNDC) is expected to grow by 9.57% in the next year. Check the estimates tab for more information on the LNDC EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
LNDC does not pay a dividend.
LANDEC CORP (LNDC) will report earnings on 2023-01-03.
LANDEC CORP (LNDC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.36).
ChartMill assigns a technical rating of 1 / 10 to LNDC. When comparing the yearly performance of all stocks, LNDC is a bad performer in the overall market: 60% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to LNDC. Both the profitability and financial health of LNDC have multiple concerns.
Over the last trailing twelve months LNDC reported a non-GAAP Earnings per Share(EPS) of -0.36. The EPS decreased by -56.52% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | -47.78% | ||
ROA | -38.31% | ||
ROE | N/A | ||
Debt/Equity | 0.99 |
ChartMill assigns a Buy % Consensus number of 86% to LNDC. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of -7.67% and a revenue growth 9.57% for LNDC